Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro

Gemcitabine resistance is a common problem of pancreatic cancer chemotherapy, and how to reverse it plays an important role in the treatment of pancreatic cancer. This study investigated the effect of emodin on the gemcitabine-resistant pancreatic cancer cell line SW1990/Gem, and explored the potent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: LIU, DIAN-LEI, BU, HEQI, LI, HONG, CHEN, HUI, GUO, HONG-CHUN, WANG, ZHAO-HONG, TONG, HONG-FEI, NI, ZHONG-LIN, LIU, HAI-BIN, LIN, SHENG-ZHANG
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2011
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3584653/
https://ncbi.nlm.nih.gov/pubmed/22159556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2011.1285
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares